Upstream Bio, Inc.
UPB
$5.96
-$0.23-3.72%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -49.80% | -97.98% | -128.39% | -128.90% | -157.91% |
| Total Depreciation and Amortization | 36.49% | 63.03% | 111.24% | 233.33% | 159.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 116.59% | 124.49% | 461.66% | 654.77% | 192.11% |
| Change in Net Operating Assets | 129.04% | 145.55% | -68.55% | -912.66% | -1,206.99% |
| Cash from Operations | -19.62% | -69.09% | -125.23% | -119.61% | -144.97% |
| Capital Expenditure | 78.85% | 67.71% | 67.71% | 9.20% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 205.53% | 156.77% | -58.23% | -3.68% | -63.61% |
| Cash from Investing | 205.08% | 156.61% | -57.15% | -3.64% | -64.20% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.17% | -98.87% | -99.12% | 2,814.34% | 2,781.65% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -99.95% | -99.95% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | 99.14% | -23.37% | -2,811.28% |
| Cash from Financing | -98.15% | -99.25% | -99.42% | 83.61% | 79.94% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,115.38% | -36.46% | -174.71% | 376.64% | -122.46% |